<DOC>
	<DOC>NCT00768222</DOC>
	<brief_summary>This is a 90-day study to evaluate cosmetic outcome and Surgical Site Infection in approximately 100 patients from 6 centers in China undergoing scheduled modified radical mastectomy for breast cancer.</brief_summary>
	<brief_title>Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery</brief_title>
	<detailed_description>Patients will be evaluated post-procedure on Days 3, 5, 7, 12, 30 and 90 for cosmetic outcome and surgical site infection.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Triclosan</mesh_term>
	<criteria>18 years of age or older with written informed consent Scheduled for a modified radical mastectomy Surgical wound classified Class I/Clean using the CDC SSI Surgical Wound Classification Unable to give consent and unlikely to comply with study requirements and complete the 90day follow up visit Undergoing surgery for modified radical mastectomy with immediate breast reconstruction, cosmetic breast operations, reduction, expansion, insertion of prothesis, duct ectasia or infective breast disease or implant Surgical wounds classified as Class II, III or IV using CDC SSI Surgical Wound Classification Has inflammatory cancers or skin ulceration Has known allergy or intolerance to triclosan Has compromised wound healing or chronic immune deficiency, for example diabetes, prolonged steroid use, AIDS or substance abuse Has serious heart and/or lung disease Has skin scar history or family history Has direct relationship to or involvement in this or other studies under the direction of the investigator or center Received an experimental drug or device within 30 days prior to the planned start of treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>wound healing</keyword>
</DOC>